Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Cancer research includes investigation of interactions between cancer cells and the immune system, helping researchers better understand how the body’s natural defenses respond to cancer. In this context, the developing field of immuno-oncology investigates how the body’s natural defenses can be used or modified to recognize and target cancer cells. and respond to cancer cells. […]

The post The Role of Immuno-Oncology in Modern Cancer Research and Treatment appeared first on Medical News Bulletin.

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

When to See an Ophthalmologist: Eye Symptoms You Shouldn’t Ignore Most eye niggles turn out to be minor. That’s worth knowing if you’re reading this a little worried. For most people, a check with the optometrist every year or two, maybe a new prescription, and that’s the end of it. Occasionally, though, your eyes show […]

The post When to See an Ophthalmologist: Eye Symptoms You Shouldn’t Ignore appeared first on Medical News Bulletin.

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Working out does not have to be only at the gym. These days, with the tech advancement and the availability of the internet, which has massive information such as workout videos, no need to pay the high gym fee. You can simply make or invest in some home equipment, or get started with the no-equipment […]

The post Five Apps to Get Fit with at-Home Workouts appeared first on Medical News Bulletin.

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Doctors have announced that a new neuroprotective drug, loberamisal, significantly increases a patient’s chance of making a full recovery after an ischaemic stroke. The much anticipated results of the phase III clinical trial were officially presented in JAMA, September 2026. Earlier this year Dr Suya Li of Beijing Tiantan Hospital, Capital Medical University, Beijing, China, showcased […]

The post New Drug Increases Ischaemic Stroke Functional Recovery Rate to 69% appeared first on Medical News Bulletin.

PHOENIX — An educational intervention increased allergy and asthma treatment knowledge among school staff, according to data presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
As the prevalence of food allergy and asthma increases among children, so do classroom emergencies, Devika Pillay, DO, an allergist at Baylor Scott & White Medical Center in Grapevine, Texas, and colleagues wrote.
“Many school nurses and school staff report inadequate resources, training and general discomfort in managing asthma/anaphylaxis emergencies,” Pillay told

PHOENIX — Families who spoke languages other than English were less likely to introduce their infants to peanut, according to data presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
These delays may put these infants at greater risk for developing peanut allergy, James Senter, MD, MPH, fellow physician, division of allergy/immunology, Ann and Robert H. Lurie Children’s Hospital of Chicago, and colleagues wrote.
“My research focuses on health disparities in allergic disease among patients and families who speak languages other than English,” Senter

PHOENIX — Significantly fewer children with eosinophilic esophagitis receiving dupilumab developed incident asthma than those receiving budesonide, according to findings presented here.
“Pediatric patients who have allergic diseases are prone to more,” Kayla Steinberger, MD, PhD, resident physician in pediatrics at West Virginia University, told Healio. “We should consider treating patients holistically and ensure patients have access to the most appropriate treatment.”
In a retrospective cohort study presented at the American College of Allergy, Asthma & Immunology Annual Scientific

PHOENIX — In statistical models and machine learning algorithms, a model using 12 variables was comparable to a model using 18 variables in predicting 30-day pediatric asthma ED readmission, according to results presented here.
Further, the best performing machine learning algorithm during testing had areas under the curves (AUCs) of 0.708 and 0.711, which fell only slightly below the AUCs of 0.74 and 0.742 with the best performing statistical model, according to the poster presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
“Our AUCs for 30-day ED

Editor’s note: This is a developing news story. Please check back soon for updates.
The FDA approved a new treatment for muscle invasive bladder cancer: Imfinzi in combination with Padcev as a neoadjuvant treatment, followed by Imfinzi as adjuvant treatment after radical cystectomy.
The treatment is approved for adults who are ineligible for or have refused cisplatin-based chemotherapy.
The treatment was evaluated in VOLGA, which included 695 patients with muscle invasive bladder cancer. Compared with radical cystectomy alone, the treatment showed statistically significant improvements in

One person died and several others were sickened in an outbreak of Escherichia coli linked to a California pumpkin patch, according to county health officials.
Tom Cuddy, public information officer for the San Luis Obispo County public health department, confirmed the death in a statement sent to Healio on Friday but gave no additional details about the person.
“This is truly a heartbreaking development, and our thoughts are with the family and everyone affected by this outbreak,” Cuddy said.
Three children were hospitalized in the outbreak, all of whom were admitted into pediatric intensive